TISSEEL KIT VH 2.0
TISSEEL KIT VH 2.0
Discontinued
DIN Number
01949012
Drug Class
Human
Market Date
Dec 31, 1992
Company
HC
osterreichisches institut fur haemoderivate ges m.b.h.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number01949012
AIG Number0952583002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
B02BD20 COMBINATIONS
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationTopical
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (9)
ANTIHEMOPHILIC FACTOR (HUMAN)Active
Strength: 50 UNIT / ML
Monograph: ANTIHEMOPHILIC FACTOR (HUMAN)
APROTININ (BOVINE)Active
Strength: 3000 UNIT / ML
Monograph: APROTININ (BOVINE)
CALCIUM CHLORIDEActive
Strength: 0.04 MMOL / ML
Monograph: CALCIUM CHLORIDE
FIBRINOGEN (HUMAN)Active
Strength: 110 MG / ML
Monograph: FIBRINOGEN (HUMAN)
PLASMAFIBRONECTIN (CIG)Active
Strength: 9 MG / ML
Monograph: PLASMAFIBRONECTIN (CIG)
PLASMINOGENActive
Strength: 120 MCG / ML
Monograph: PLASMINOGEN
PROTEINActive
Strength: 130 MG / ML
Monograph: PROTEIN
THROMBIN (BOVINE)Active
Strength: 500 UNIT / ML
Monograph: THROMBIN (BOVINE)
THROMBIN (BOVINE)Active
Strength: 4 UNIT / ML
Monograph: THROMBIN (BOVINE)